Authors
Loading...
Preclinical study reveals heterogeneous, organ-specific CRISPR-Cas9 off-target cuts and translocations in mouse models, highlighting the need for localized safety assessments.
Madsen et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: